XENE icon

Xenon Pharmaceuticals
XENE

Overview Fund Trends Analyst Outlook Journalist POV

58 hedge funds and large institutions have $110M invested in Xenon Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 23 increasing their positions, 6 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

53% less capital invested

Capital invested by funds: $234M → $110M (-$124M)

Holders
58
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$6K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$3.93M
2
+$2.26M
3
+$2.05M
4
BlackRock
BlackRock
New York
+$1.79M
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$1.14M

Top Sellers

1
-$11.8M
2
-$7.01M
3
-$5.09M
4
JG
Jefferies Group
New York
-$4.3M
5
BC
Boxer Capital
California
-$3.96M
Name Holding Trade Value Shares
Change 		Change in
Stake
51
$27K
52
$24K
53
$17K
54
$8K
55
$4K
56
$2K
57
$2K
58
$1K
59
–
60
–
61
–
62
–
63
–
64
–
65
–
66
–
67
–
68
–
69
–
70
–
71
–
1 2
3